Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

381.88 -0.58 (-0.15%)
Streaming Delayed Price Updated: 2:44 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stryker's Debt Overview
Shares of Stryker (NYSE:SYK) fell by 5.13% in the past three months. Before having a look at the importance of debt, let us look at how much debt Stryker has. Stryker's... 
Via Benzinga
This Foreboding Sign Looms Over Stryker's Chart
If history is any guide, there may be trouble ahead for shares of Stryker (NYSE:SYK). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
VCRA Stock: 8 Things for Vocera Investors to Know About the Stryker Deal as Shares Soar
Vocera Communications (VCRA) stock is on the move Thursday as investors react to news of Stryker (SYK) acquiring the company. 
Via InvestorPlace
Stryker Dives As It Announces $3.09 Billion Takeover Of Vocera Communications
Stryker will buy health care communications company Vocera Communications. 
Via Investor's Business Daily
Expert Ratings For Stryker
Over the past 3 months, 4 analysts have published their opinion on Stryker (NYSE:S... 
Via Benzinga
Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... 
Via Benzinga
Analyzing Stryker's Unusual Options Activity
On Friday, shares of Stryker (NYSE:SYK) saw unusual options ... 
Via Benzinga
What 12 Analyst Ratings Have To Say About Stryker
Within the last quarter, Stryker (NYSE:SYK) has observed the... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022
Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE: 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Barclays raised the price target on Hewlett Packard Enterprise Company (NYSE: 
Via Benzinga
MBOT Stock Alert: Why Is Microbot Soaring 50% Today?
Microbot Medical is catching investors' attention on Monday, with shares up more than 70% at one point during the day. Here's why. 
Via InvestorPlace
Positive Signals From Regulators Spells Good News for This Industry
Photo by Darren Halstead on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Why Did the Bot Cross the Road? This Company Believes Its Delivery Robots Are a Game-Changer
Image courtesy: Daxbot The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
Is This Powerhouse Medical Devices Stock a Buy?
Stryker is one of the largest medical device companies in the world, yet it appears to have plenty of growth left in the tank. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE: 
Via Benzinga
Stryker Q3 Earnings Miss Expectations, Downgrades FY21 Guidance
Stryker Corp (NYSE: SYK) posted Q3 adjusted EPS of $2.20, +2.8% Y/Y, missing the consensus of $2.28. Stryker reported continued headwinds from the COVID-19 pandemic,... 
Via Benzinga
Topics Earnings
Exposures COVID-19 Financial
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
Upgrades For CarMax Inc (NYSE: 
Via Benzinga
Stryker Corp (SYK) Q3 2021 Earnings Call Transcript
SYK earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Stryker Q3 Earnings
Stryker (NYSE:SYK) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Stryker... 
Via Benzinga
Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings
Stock futures were pointing to a higher open even before Goldman Sachs (NYSE: GS) reported better than expected earnings. Goldman rose 2.25% before the open helping to... 
Via Benzinga
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
'Fast Money Halftime Report' Picks For September 13
On CNBC's "Fast Money Halftime Report," Shannon Saccocia said Stryker Corporation (NYSE: SYK) has had a really nice run since last year. She sees more upside... 
Via Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Stryker Acquires Provider Of Blood Loss Monitoring Platform
Stryker Corporation (NYSE: SYK) has acquired Gauss Surgical for an undisclosed consideration. Gauss Surgical is a medical device company that has developed... 
Via Benzinga
Is This Medical-Device Company a Buy After Solid Earnings?
The company's second-quarter results suggest it boasts positive operating fundamentals and a decent balance sheet. 
Via The Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
10 Biggest Price Target Changes For Wednesday
Needham lifted Alphabet Inc. (NASDAQ: GOOGL) price target from $2,700 to $3,200. Alphabet shares gained 3.8% to $2,737.37 in pre-market trading. Barclays lifted the price... 
Via Benzinga
Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook
The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.